Similarly, disease-free survival time (DFS) was the highest in melanomas with high CYP24A1 in comparison to melanomas with low or absent CYP24A1 (1607, 539, 459 median days, respectively) (Figure 4B). Here, CYP24A1 is linked to melanoma.